
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | $608.2M | $784.6M | $1B | $259M | $331.8M | |
Gross Profit | $126.4M | $195.1M | $260.5M | $65.4M | $84.1M | |
Operating Income | $5.5M | $36.9M | $68.6M | $14.2M | $21.9M | |
EBITDA | $48.3M | $88.8M | $132.4M | $31.5M | $42.7M | |
Diluted EPS | -$0.42 | $0.41 | $1.20 | $0.12 | $0.22 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | -- | -- | -- | $352M | $403M | |
Total Assets | -- | -- | -- | $1B | $1.2B | |
Current Liabilities | -- | -- | -- | $111.3M | $134.3M | |
Total Liabilities | -- | -- | -- | $424.3M | $502.2M | |
Total Equity | -- | -- | -- | $580.8M | $726.2M | |
Total Debt | -- | -- | -- | -- | -- |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | -- | $109.8M | $161.2M | $38.4M | $38.6M | |
Cash From Investing | -- | -$133.4M | -$190.3M | -$33.7M | -$115.8M | |
Cash From Financing | -- | $330M | -$10.7M | -$8M | $489K | |
Free Cash Flow | -- | -$23.6M | $50.9M | $4.7M | $2.7M |
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company’s operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
In the current month, CAVA has received 9 Buy ratings 6 Hold ratings, and 0 Sell ratings. The CAVA average analyst price target in the past 3 months is $110.42.
According to analysts, the consensus estimate is that Cava Group share price will rise to $110.42 per share over the next 12 months.
Analysts are divided on their view about Cava Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cava Group is a Sell and believe this share price will drop from its current level to $90.00.
The price target for Cava Group over the next 1-year time period is forecast to be $110.42 according to 15 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Cava Group is a Buy. 9 of 15 analysts rate the stock a Buy at this time.
You can purchase shares of Cava Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cava Group shares.
Cava Group was last trading at $86.76 per share. This represents the most recent stock quote for Cava Group. Yesterday, Cava Group closed at $88.98 per share.
In order to purchase Cava Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.